The Pharmaceutical Market: Norway

DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/x6sbkr/the) has announced the addition of the "The Pharmaceutical Market: Norway" report to their offering.

The macro-environment for the Norwegian pharmaceutical industry is improving. Politically, the centre-left coalition is expected to hold together at least until the general election but the risk of the coalition breaking up has grown. Economically, the recession was far less pronounced in Norway than in most other European countries and economic recovery is now strengthening.

Demographically, the population is ageing, increasing demand for pharmaceuticals in the near term.

The introduction of international reference pricing has had a moderating effect on Norwegian pharmaceutical price levels, and a step-price system for off-patent drugs has ensured that prices for all generics have fallen. Important steps towards cost-containment have also been taken for reimbursable pharmaceuticals, including the use of a first-choice system.

A report by the Business Research Foundation (SNF) has shown that Norwegian pharmaceutical prices are among the lowest in Western Europe. Therefore, market growth is a result of increased consumption, largely due to the ageing population and the introduction of new drugs on the market. Norway is receptive to new drugs, as long as they are cost-effective and have proven therapeutic benefits.

Although Norway is not part of the European Union, the process for pharmaceutical registration has been aligned to EU regulations.

Key Topics Covered:

1. SWOT

2. Political

3. Economic

4. Business Environment

5. Industry Forecast

6. Pharmaceutical Market Forecast

7. Healthcare Market Forecast

8. Norway

9. Pharmaceutical Trade Forecast

10. Macroeconomic Forecasts

11. Economic Analysis

12. Industry Risk Reward Ratings

13. Western Europe Risk/Reward Ratings

14. Norway Risk/Reward Ratings

15. Rewards

16. Risks

17. Market Overview

18. Industry Trends And Developments

19. Epidemiology

20. Healthcare Sector

21. Clinical Trials

22. Regulatory Development

23. Pricing Regime

24. Reimbursement Regime

25. Competitive Landscape

26. Demographic Forecast

27. Glossary

28. Methodology

29. Pharmaceutical Expenditure Forecast Model

30. Healthcare Expenditure Forecast Model

31. Notes On Methodology

32. Risk/Reward Ratings Methodology

33. Ratings Overview

34. Indicator Weightings

For more information visit http://www.researchandmarkets.com/research/x6sbkr/the

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals